Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.


Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

New ADHD drug for young people

  • Comment

A new drug has been approved for the treatment of attention deficit/hyperactivity disorder in children and adolescents.

Lisdexamfetamine dimesylate (Elvanse) is a single-daily dose long-acting prodrug stimulant.

It has received marketing authorisation from the Medicines and Healthcare products Regulatory Agency for the treatment of ADHD in children aged six years and over when response to previous methylphenidate treatment is considered clinically inadequate.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs